98%
921
2 minutes
20
Importance: Hospice positively impacts care at the end of life for patients and their families. However, compared to the general Medicare population, patients on dialysis are half as likely to receive hospice. Concurrent hospice and dialysis care offers an opportunity to improve care for people living with end-stage kidney disease (ESKD).
Objective: We sought to (1) develop a conceptual model of the Program and (2) identify key components, resources, and considerations for further implementation.
Design: We conducted a template analysis of qualitative interviews and convened a community advisory panel (CAP) to get feedback on current concurrent care design and considerations for dissemination and implementation.
Participants: Thirty-nine patients with late-stage chronic kidney disease (CKD), family caregivers, bereaved family caregivers, hospice clinicians, nephrology clinicians, administrators, and policy experts participated in interviews. A purposive subset of 19 interviewees composed the CAP.
Main Measures: Qualitative feedback on concurrent care design refinements, implementation, and resources.
Key Results: Participants identified four themes that define an effective model of concurrent hospice and dialysis: it requires (1) timely goals-of-care conversations and (2) an interdisciplinary approach; (3) clear guidelines ensure smooth transitions for patients and families; and (4) hospice payment policy must support concurrent care. CAP participants provided feedback on the phases of an effective model of concurrent hospice and dialysis, and resources, including written and interactive educational materials, communication tools, workflow processes, and order sets.
Conclusions: We developed a conceptual model for concurrent hospice and dialysis care and a corresponding resource list. In addition to policy changes, clinical implementation and educational resources can facilitate scalable and equitable dissemination of concurrent care. Concurrent hospice and dialysis care must be systematically evaluated via a hybrid implementation-effectiveness trial that includes the resources outlined herein, based on our conceptual model of concurrent care delivery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043284 | PMC |
http://dx.doi.org/10.1007/s11606-023-08504-w | DOI Listing |
Am J Med Sci
August 2025
Department of Cardiac Surgery, Yale University, New Haven, CT.
Background: Despite noteworthy developments and advancements in the field of cardiovascular medicine, myocardial infarction (MI) remains one of the leading causes of mortality worldwide.
Aim: To investigate the existence of disparities within MI-related locations of deaths in the United States.
Methods: Data on death certificates from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC-WONDER) was utilized to evaluate trends in the locations of MI-related mortality from 1999 to 2020.
Psychooncology
August 2025
College of Nursing, University of Utah, Utah, Utah, USA.
Objective: Given the effects of patient symptom burden and the unclear temporal associations with family caregiver sleep difficulty and psychological mood states, we longitudinally examined the day-to-day concurrent impacts of caregiver-perceived patient symptom burden, caregiver self-reported sleep difficulty, and anxious and depressive feelings (mood) in home hospice family caregivers of patients with cancer.
Methods: In a secondary data analysis, we utilized dynamic structural equation modeling to observe the interdependent evolution of caregiver self-perception of sleep difficulty and mood, and caregiver perception of patient symptoms in 141 family caregivers from 12 home hospice programs.
Results: During hospice care, caregiver perception of patient symptom burden impacted caregivers' self-reported feelings of anxiousness and depressed mood (b = 0.
Lancet
August 2025
State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Special Administrative Region, China. Electronic address:
Background: Adagrasib is a KRAS inhibitor that demonstrated promising activity against KRAS-mutated advanced non-small-cell lung cancer (NSCLC) in a phase 2 trial. Here we aimed to compare the efficacy and safety of adagrasib versus docetaxel in patients with KRAS-mutated advanced NSCLC previously treated with chemotherapy and immunotherapy.
Methods: KRYSTAL-12 is a randomised, multicentre, open-label, phase 3 trial conducted at 230 centres in 22 countries.
J Pain Symptom Manage
August 2025
University of Utah (C.D.C, DM, TP, BH, MH), Salt Lake City, UT.
Context: Pediatric hospice provides care for children during the final stages of a terminal illness, usually defined as a prognosis of six months or less. There is limited data to inform hospice utilization in children among different hospice diagnoses.
Objective: The objective of this study is to perform a retrospective analysis of pediatric hospice patients to better describe clinical trends and utilization among different hospice diagnoses.
Pediatrics
September 2025
College of Nursing, University of Tennessee, Knoxville, Knoxville, Tennessee.
The Patient Protection and Affordable Care Act (ACA) required all state Medicaid programs to pay for both curative and hospice services for children and adolescents. The purpose of this Special Article report is to quantify and describe the use of concurrent care for children, including a depiction of the barriers and benefits according to community-based hospice organizations in the United States. A total of 295 hospice organizations from 50 states and Washington, DC responded to the National Alliance for Care at Home call for engagement.
View Article and Find Full Text PDF